Jason Ryan, Chief Financial Officer at Foundation Medicine, Inc. (FMI), sold 503 shares at $34.55 ($17K) on 2017-04-18, disclosed to the SEC on 2017-04-20.
Scheduled sale ($17k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| WGS | BUY | 2023-11-20 | $233K | — | Filing → |
| WGS | SELL | 2023-10-18 | $134 | — | Filing → |
| SMFR | SELL | 2023-01-04 | $19K | — | Filing → |